Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lycia Therapeutics
Biotech
Lilly-backed Lycia Therapeutics nabs $70M round
Lycia Therapeutics has grabbed a $70 million series B for its next-generation degradation approach to zero in on the untapped extracellular proteome.
Ben Adams
Sep 9, 2021 7:00am
Lilly doubles down on protein degradation with $35M Lycia deal
Aug 25, 2021 11:17am
BioTheryX skips the SPAC fervor in favor of eventual IPO
May 21, 2021 10:50am
Lycia uncloaks with $50M to tackle protein degradation
Jun 9, 2020 8:00am
